Scarica l'app Stockscreener
241.12
1.11%
-2.71
Dopo l'orario di chiusura:
241.12
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
How sensitive is West Pharmaceutical Services Inc. to inflationGold Moves & Weekly Breakout Watchlists - mfd.ru
West Pharmaceutical Services (WST) is Returning to Sustainable Volume Growth - Insider Monkey
Vanguard Group Inc. Buys 388,144 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by ICICI Prudential Asset Management Co Ltd - MarketBeat
Are Wall Street Analysts Bullish on West Pharmaceutical Services Stock? - Yahoo Finance
Customer Concentration Risk: How Dependence on Key Accounts Threatens West Pharmaceutical’s Financial Stability - The Globe and Mail
Risk Recap: What’s the outlook for West Pharmaceutical Services Inc.’s sectorWeekly Trend Recap & AI Enhanced Market Trend Forecasts - mfd.ru
Pharmaceutical Packaging Market Trends and Growth - GlobeNewswire
Pharmaceutical Packaging Market Trends and Growth Projections to 2030 Featuring Profiles of AptarGroup, Amcor, SGD Pharma, West Pharmaceutical Services, SCHOTT Pharma and Other Key Players - Yahoo Finance
Exton-Based West Pharmaceutical Reports Higher Q4 Sales, Earnings - MyChesCo
5 Insightful Analyst Questions From West Pharmaceutical Services's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call - TradingView
Assessing West Pharmaceutical Services (WST) Valuation After Earnings Beat Guidance And US$1b Buyback Announcement - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP), Galapagos (GLPG) and West Pharmaceutical Services (WST) - The Globe and Mail
West Pharmaceutical Services, Inc. (NYSE:WST) Declares $0.22 Quarterly Dividend - MarketBeat
Assetmark Inc. Sells 26,486 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Share Repurchase Plan Declared by West Pharmaceutical Services (NYSE:WST) Board of Directors - Defense World
West Pharmaceutical Services (NYSE:WST) to Buyback $1.00 billion in Outstanding Shares - MarketBeat
West Pharmaceutical announces up to $1B share repurchase program - MSN
West Pharmaceutical Services Maintains Quarterly Dividend, Authorizes $1 Billion Share Repurchase - marketscreener.com
West Pharmaceutical Services, Inc. Declares Regular Quarterly Dividend on Common Stock, Payable on May 6, 2026 - marketscreener.com
West Pharmaceutical Declares Quarterly Dividend and Share Repurchase Program - Intellectia AI
West Announces Quarterly Dividend and Share Repurchase Program - Nasdaq
Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term - Yahoo Finance
How West Pharmaceutical Services Inc. (WST) Affects Rotational Strategy Timing - Stock Traders Daily
West Pharmaceutical Services launches Synchrony S1 prefillable syringe system - Traders Union
West Pharmaceutical Services (WST) Stock Analysis: A Look At Its 27% Potential Upside - DirectorsTalk Interviews
WST's Q4 earnings & sales beat, SmartDose sale by mid-2026, stock up - MSN
West Pharmaceutical Services, Inc. (NYSE:WST) Sees Significant Increase in Short Interest - MarketBeat
What’s the outlook for West Pharmaceutical Services Inc.’s sectorPrice Action & Technical Confirmation Alerts - mfd.ru
Earnings Release: Here's Why Analysts Cut Their West Pharmaceutical Services, Inc. (NYSE:WST) Price Target To US$319 - 富途牛牛
Cibc World Market Inc. Has $4.88 Million Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Caprock Group LLC Purchases New Shares in West Pharmaceutical Services, Inc. $WST - MarketBeat
How Investors Are Reacting To West Pharmaceutical (WST) GLP-1 Momentum And Upbeat 2026 Sales Guidance - Sahm
West Pharmaceutical Services (WST): Barclays Lowers Price Target - GuruFocus
Stephens Cuts Price Target on West Pharmaceutical Services to $320 From $350, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Q4 Earnings Call Highlights - MarketBeat
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates - MSN
West Pharma forecasts 2026 profit above estimates on strong demand for drug components - 104.1 WIKY
West Pharmaceutical Services (WST) Is Up 5.2% After Strong 2025 Results And 2026 Organic Growth Outlook - Yahoo Finance
Earnings call transcript: West Pharmaceutical Services Q4 2025 earnings beat expectations - Investing.com Canada
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations - Investing.com Nigeria
West Pharmaceutical Services (NYSE:WST) Issues Quarterly Earnings Results, Beats Expectations By $0.21 EPS - MarketBeat
West Pharmaceutical Services Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI
West Pharmaceutical Services's (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars - Finviz
WST's Q4 Earnings & Sales Beat, SmartDose Sale by Mid-2026, Stock Up - Finviz
Iron Mountain Projects Double-Digit Growth in 2026 - Investing.com
West Pharmaceutical Q4 2025 slides: Revenue up 7.5%, EPS exceeds expectations By Investing.com - Investing.com India
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
West Pharmaceutical Services (NYSE:WST) Issues FY 2026 Earnings Guidance - MarketBeat
West Pharmaceutical Q4 EPS Beats Estimates; Guides 2026 Sales Growth of 5% to 7% - AlphaStreet News
West Pharmaceutical (WST) Exceeds Market Expectations with Stron - GuruFocus
West Pharmaceutical Services, Inc. $WST Shares Sold by ING Groep NV - MarketBeat
0.39%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):